Eva Renee Barnett
2022
In 2022, Eva Renee Barnett earned a total compensation of $4.4M as Chief Financial Officer at Immunovant.
Compensation breakdown
| Bonus | $328,027 |
|---|---|
| Option Awards | $2,126,272 |
| Salary | $198,485 |
| Stock Awards | $1,765,800 |
| Other | $8,467 |
| Total | $4,427,051 |
Barnett received $2.1M in option awards, accounting for 48% of the total pay in 2022.
Barnett also received $328K in bonus, $198.5K in salary, $1.8M in stock awards and $8.5K in other compensation.
Rankings
In 2022, Eva Renee Barnett's compensation ranked 744th out of 5,625 executives tracked by ExecPay. In other words, Barnett earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 744 out of 5,625 | 87th |
Division Manufacturing | 331 out of 3,053 | 89th |
Major group Chemicals And Allied Products | 104 out of 1,380 | 93rd |
Industry group Drugs | 91 out of 1,281 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 21 out of 295 | 93rd |
Source: SEC filing on June 30, 2022.
Barnett's colleagues
We found two more compensation records of executives who worked with Eva Renee Barnett at Immunovant in 2022.